Implantable lens offers new hope for nearsightedness

NCT ID NCT04283149

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study tested the safety and effectiveness of the EVO/EVO+ Visian Implantable Collamer Lens (ICL) in 327 adults with moderate to high nearsightedness (with or without astigmatism). The lens is surgically placed inside the eye to correct vision. Researchers tracked side effects, eye cell health, and vision changes over 6 to 36 months. The goal was to see if the lens is a safe and reliable option for vision correction.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MYOPIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Aloha Laser Vision, LLC

    Honolulu, Hawaii, 96814, United States

  • Barnett Dulaney Perkins

    Phoenix, Arizona, 85106, United States

  • Brinton Vision

    St Louis, Missouri, 63141, United States

  • Cleveland Eye Clinic

    Brecksville, Ohio, 44141, United States

  • Durrie Vision

    Overland Park, Kansas, 66210, United States

  • Hoopes Vision/Hoopes, Durrie, Rivera Research

    Draper, Utah, 84020, United States

  • Key-Whitman Eye Center

    Dallas, Texas, 75243, United States

  • Kremer Eye Center

    King of Prussia, Pennsylvania, 19406, United States

  • Kugler Vision, PC

    Omaha, Nebraska, 68118, United States

  • Parkhurst NuVision

    San Antonio, Texas, 78229, United States

  • Price Vision Group,

    Indianapolis, Indiana, 46260, United States

  • Solomon Eye Physicians and Surgeons/Bowie Vision Institute

    Bowie, Maryland, 20716, United States

  • The Eye Institute of Utah

    Salt Lake City, Utah, 84107, United States

  • Vance Thompson Vision

    Sioux Falls, South Dakota, 57108, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.